These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 9688098)

  • 1. Universal childhood hepatitis B vaccination: infants vs. preadolescents, the Canadian perspective.
    Scheifele D
    Pediatr Infect Dis J; 1998 Jul; 17(7 Suppl):S35-7. PubMed ID: 9688098
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatitis B infection in Minnesota: a case for universal immunization.
    Osterholm MT
    Pediatr Infect Dis J; 1998 Jul; 17(7 Suppl):S30-4. PubMed ID: 9688097
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatitis B immunization of Asian Pacific Islanders in the United States.
    Watson B
    Pediatr Infect Dis J; 1998 Jul; 17(7 Suppl):S38-42. PubMed ID: 9688099
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The evolving efforts to control hepatitis B virus.
    Arnot R
    Pediatr Infect Dis J; 1998 Jul; 17(7 Suppl):S26-9. PubMed ID: 9688096
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP) part 1: immunization of infants, children, and adolescents.
    Mast EE; Margolis HS; Fiore AE; Brink EW; Goldstein ST; Wang SA; Moyer LA; Bell BP; Alter MJ;
    MMWR Recomm Rep; 2005 Dec; 54(RR-16):1-31. PubMed ID: 16371945
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effectiveness and impact of the hepatitis B vaccination program in preadolescents in Catalonia 21 years after its introduction.
    Borràs E; Urbiztondo L; Carmona G; Jané M; Barrabeig I; Rosa Sala M; Jorgina Balañà JP; Company M; Parrón I; Godoy P; Rius C; Soldevila N; Cabezas C; Domínguez À;
    Vaccine; 2019 Feb; 37(9):1137-1141. PubMed ID: 30709729
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Perinatal hepatitis B transmission and vaccination timing in a managed care cohort: assessment of the temporary delay in newborn hepatitis B vaccination due to thimerosal content.
    Chang S; Begier EM; Schech SD; Venus P; Shatin D; Braun MM; Ball R
    Pediatr Infect Dis J; 2007 Apr; 26(4):329-33. PubMed ID: 17414397
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surveillance for acute viral hepatitis - United States, 2007.
    Daniels D; Grytdal S; Wasley A;
    MMWR Surveill Summ; 2009 May; 58(3):1-27. PubMed ID: 19478727
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute hepatitis B 14 years after the implementation of universal vaccination in Italy: areas of improvement and emerging challenges.
    Mele A; Tosti ME; Mariano A; Pizzuti R; Ferro A; Borrini B; Zotti C; Lopalco P; Curtale F; Balocchini E; Spada E;
    Clin Infect Dis; 2008 Mar; 46(6):868-75. PubMed ID: 18269332
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Benefits of early hepatitis B immunization programs for newborns and infants.
    Van Herck K; Van Damme P
    Pediatr Infect Dis J; 2008 Oct; 27(10):861-9. PubMed ID: 18776823
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidemiology of hepatitis B and hepatitis B virus infection in United States children.
    Shepard CW; Finelli L; Fiore AE; Bell BP
    Pediatr Infect Dis J; 2005 Sep; 24(9):755-60. PubMed ID: 16148839
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevention of hepatitis B virus transmission by immunization. An economic analysis of current recommendations.
    Margolis HS; Coleman PJ; Brown RE; Mast EE; Sheingold SH; Arevalo JA
    JAMA; 1995 Oct; 274(15):1201-8. PubMed ID: 7563509
    [TBL] [Abstract][Full Text] [Related]  

  • 13. School-based adolescent hepatitis B immunization programs in the United States: strategies and successes.
    Cassidy W
    Pediatr Infect Dis J; 1998 Jul; 17(7 Suppl):S43-6. PubMed ID: 9688100
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serological and molecular epidemiological outcomes after two decades of universal infant hepatitis B virus (HBV) vaccination in Nunavut, Canada.
    Huynh C; Minuk GY; Uhanova J; Baikie M; Wong T; Osiowy C
    Vaccine; 2017 Aug; 35(35 Pt B):4515-4522. PubMed ID: 28736196
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surveillance for acute viral hepatitis--United States, 2006.
    Wasley A; Grytdal S; Gallagher K;
    MMWR Surveill Summ; 2008 Mar; 57(2):1-24. PubMed ID: 18354374
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Should Canada and the United States universally vaccinate infants against hepatitis B? A cost-effectiveness analysis.
    Krahn M; Detsky AS
    Med Decis Making; 1993; 13(1):4-20. PubMed ID: 8433635
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis B vaccination coverage among U.S. adolescents, National Immunization Survey-Teen, 2006.
    Jain N; Hennessey K
    J Adolesc Health; 2009 Jun; 44(6):561-7. PubMed ID: 19465320
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of the quebec school-based hepatitis B immunization program and potential benefit of the addition of an infant immunization program.
    Gîlca V; Duval B; Boulianne N; Dion R; De Serres G
    Pediatr Infect Dis J; 2006 Apr; 25(4):372-4. PubMed ID: 16567995
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effectiveness and impact of hepatitis B virus vaccination of children with at least one parent born in a hepatitis B virus endemic country: an early assessment.
    Hontelez JA; Hahné S; Koedijk FH; de Melker HE
    J Epidemiol Community Health; 2010 Oct; 64(10):890-4. PubMed ID: 19822551
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of state policies on vaccine coverage by age 13 in an insured population.
    Olshen E; Mahon BE; Wang S; Woods ER
    J Adolesc Health; 2007 May; 40(5):405-11. PubMed ID: 17448397
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.